Related references
Note: Only part of the references are listed.In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation
Stefani Vircheva et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation
L. SEKUT et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Increased Caffeine Consumption Is Associated with Reduced Hepatic Fibrosis
Apurva A. Modi et al.
HEPATOLOGY (2010)
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2009)
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment
Christine Carter-Kent et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
A pilot trial of pentoxifylline in nonalcoholic steatohepatitis
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis
SK Satapathy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet
SWP Koppe et al.
JOURNAL OF HEPATOLOGY (2004)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2003)
Pentoxifylline diminished acetaldehyde-induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression
E Hernández et al.
PHARMACOLOGICAL RESEARCH (2002)
Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis
C Raetsch et al.
GUT (2002)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
Share Paper
